Similar articles

• Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.

  Hirsch S. Hirsch S. Compr Ther. 2009 Summer;35(2):91-5. Compr Ther. 2009. PMID: 19618757 Review.
• Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?

  Lim S. Lim S. Acta Med Indones. 2008 Jan;40(1):34-7. Acta Med Indones. 2008. PMID: 19054878 Review.
• Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers.

  Berl T. Berl T. Nephrol Dial Transplant. 2008 Aug;23(8):2443-7. doi: 10.1093/ndt/gfn239. Epub 2008 May 8. Nephrol Dial Transplant. 2008. PMID: 18467376 Review. No abstract available.
• The hazards of dual renin-angiotensin blockade in chronic kidney disease.

  Ku E, Park J, Vidhun J, Campese V. Ku E, et al. Arch Intern Med. 2009 Jun 8;169(11):1015-8. doi: 10.1001/archinternmed.2009.128. Arch Intern Med. 2009. PMID: 19506167 No abstract available.
• Evolving understanding of the renin-angiotensin-aldosterone system: pathophysiology and targets for therapeutic intervention.

  Gradman AH. Gradman AH. Am Heart J. 2009 Jun;157(6 Suppl):S1-6. doi: 10.1016/j.ahj.2009.04.005. Am Heart J. 2009. PMID: 19450719 Review. No abstract available.